A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer With Rare Mutations in HER2
Clinical trial NCT05411276 · UNKNOWN
Trial details
- NCT number
- NCT05411276
- Sponsor
- Beijing Chest Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.